Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,655 | Dovepress* | 11,383+ | 1,752 | 13,135 | |
PubMed Central* | 1,272 | 494 | 1,766 | ||
Totals | 12,655 | 2,246 | 14,901 | ||
*Since 16 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar